Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion type Assertion NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_head.
- NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_provenance.
- NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion evidence source_evidence_literature NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_provenance.
- NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion SIO_000772 9168435 NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_provenance.
- NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion wasDerivedFrom befree-2016 NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_provenance.
- NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_assertion wasGeneratedBy ECO_0000203 NP1373834.RAKqC4UMx1HzMq6fcw5ZMsCTyqJMYk2Id9EZrSA1i41IM130_provenance.